These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8831772)

  • 1. Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments.
    Gibson S; McGuire R; Rees DC
    J Med Chem; 1996 Sep; 39(20):4065-72. PubMed ID: 8831772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
    Huang B; Li C; Chen W; Liu T; Yu M; Fu L; Sun Y; Liu H; De Clercq E; Pannecouque C; Balzarini J; Zhan P; Liu X
    Eur J Med Chem; 2015 Mar; 92():754-65. PubMed ID: 25626145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protonated polycyclic aromatic nitrogen heterocyclics: proton affinities, polarizabilities, and atomic and ring charges of 1-5-ring ions.
    Maclagan RG; Gronert S; Meot-Ner Mautner M
    J Phys Chem A; 2015 Jan; 119(1):127-39. PubMed ID: 25479334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic annulation strategy for naphthalenes fused at 1,2- and 3,4-positions with two heterocycles.
    Zhang M; An HY; Zhao BG; Xu JH
    Org Biomol Chem; 2006 Jan; 4(1):33-5. PubMed ID: 16357990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explorations of molecular structure-property relationships.
    Seybold PG
    SAR QSAR Environ Res; 1999; 10(2-3):101-15. PubMed ID: 10491848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mitchell ML; Son JC; Lee IY; Lee CK; Kim HS; Guo H; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Eisenberg G; Geleziunas R; Xu L; Kim CU
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1585-8. PubMed ID: 20137928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Ruiz-Caro J; Basavapathruni A; Kim JT; Bailey CM; Wang L; Anderson KS; Hamilton AD; Jorgensen WL
    Bioorg Med Chem Lett; 2006 Feb; 16(3):668-71. PubMed ID: 16298131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
    Tian Y; Du D; Rai D; Wang L; Liu H; Zhan P; De Clercq E; Pannecouque C; Liu X
    Bioorg Med Chem; 2014 Apr; 22(7):2052-9. PubMed ID: 24631361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
    San Juan AA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of functionalized polycyclic aromatic compounds via a formal [2 + 2]-cycloaddition.
    Nagamoto Y; Yamaoka Y; Fujimura S; Takemoto Y; Takasu K
    Org Lett; 2014 Feb; 16(3):1008-11. PubMed ID: 24437688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a butterfly-like configuration of structurally diverse allosteric inhibitors of the HIV-1 reverse transcriptase.
    Mager PP
    Drug Des Discov; 1996 Dec; 14(3):241-57. PubMed ID: 9017366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in quinoline Reissert derivatives with HIV-1 reverse transcriptase inhibitory activity.
    Font M; Monge A; Ruiz I; Heras B
    Drug Des Discov; 1997 Apr; 14(4):259-72. PubMed ID: 9197978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity.
    Kroeger Smith MB; Rouzer CA; Taneyhill LA; Smith NA; Hughes SH; Boyer PL; Janssen PA; Moereels H; Koymans L; Arnold E
    Protein Sci; 1995 Oct; 4(10):2203-22. PubMed ID: 8535257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzotrifuranone: synthesis, structure, and access to polycyclic heteroaromatics.
    Li Y; Lampkins AJ; Baker MB; Sumpter BG; Huang J; Abboud KA; Castellano RK
    Org Lett; 2009 Oct; 11(19):4314-7. PubMed ID: 19715287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protonation energies of 1-5-ring polycyclic aromatic nitrogen heterocyclics: comparing experiment and theory.
    Wiseman A; Sims LA; Snead R; Gronert S; Maclagan RG; Meot-Ner Mautner M
    J Phys Chem A; 2015 Jan; 119(1):118-26. PubMed ID: 25479250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between resonance energy per pi-electron and carcinogenicity in arenes.
    Kurihara T; Motohashi N; Shimizu A; Pang GL; Molnár J
    Anticancer Res; 1996; 16(2):605-12. PubMed ID: 8687104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Computer-aided prediction of the mutagenic activity substituted polycyclic compounds].
    Liubimova IK; Abilev SK; Gal'berstam NM; Baskin II; Paliulin VA; Zefirov NS
    Izv Akad Nauk Ser Biol; 2001; (2):180-6. PubMed ID: 11357382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure--activity relationship studies of 1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea, a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1.
    Weitman M; Lerman K; Nudelman A; Major DT; Hizi A; Herschhorn A
    Eur J Med Chem; 2011 Feb; 46(2):447-67. PubMed ID: 21159409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
    Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.